Free account + included starter software — credential review typically takes 1–2 business days. See how it works
NDC 71288-0109-20

Cytarabine 2 g/20mL INJECTION, SOLUTION

Available — 2-Day Shipping
NDC
71288-0109-20
Generic Name
Cytarabine
Brand Name
Cytarabine
Strength
2 g/20mL
Dosage Form
INJECTION, SOLUTION
Route
INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Package Size
Labeler
Meitheal Pharmaceuticals Inc.

FDA Drug Information

Indications & Usage

INDICATIONS AND USAGE Cytarabine Injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of Cytarabine Injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia.

Important Warnings

WARNINGS (See boxed WARNING ) Cytarabine is a potent bone marrow suppressant. Therapy should be started cautiously in patients with pre-existing drug-induced bone marrow suppression. Patients receiving this drug must be under close medical supervision and, during induction therapy, should have leucocyte and platelet counts performed daily. Bone marrow examinations should be performed frequently af…

Source: FDA. For professional use only. Not a substitute for prescribing information.

Order NDC 71288-0109-20 at Wholesale

Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).